NASDAQ · STIM
Neuronetics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for STIM: Nov 04, 2026
Neuronetics, Inc. Common Stock is expected to report earnings on 11/04/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.08. The reported EPS for the same quarter last year was $-0.13.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Dec 2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · The Motley Fool · MarketBeat- Zacks · Oct 27, 4:15 PM EDTBeta Bionics, Inc. (BBNX) Reports Q3 Loss, Beats Revenue EstimatesBeta Bionics, Inc. (BBNX) delivered earnings and revenue surprises of +1.89% and +0.96%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 21, 6:10 AM EDTIntegra LifeSciences (IART) Surpasses Q3 Earnings EstimatesIntegra (IART) delivered earnings and revenue surprises of +5.36% and -0.81%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Fintel · Sep 11, 7:43 PM EDTB. Riley Securities Initiates Coverage of Neuronetics at BuyFintel reports that on September 11, 2026, B. Riley Securities initiated coverage of Neuronetics (NASDAQGM:STIM) with a Buy recommendation.Neuronetics, Inc., based in the United States, operates primarily within the medical device industry, focusing on pioneering treatments for p
- The Motley Fool · Aug 18, 11:43 AM EDTNeuronetics (STIM) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 11, 12:04 PM EDTNeuronetics Q2 Earnings Call HighlightsNeuronetics (NASDAQ:STIM) reported second-quarter 2026 revenue growth, a sharply narrower net loss and positive adjusted EBITDA as its Greenbrook clinic business expanded and the company introduced additional commercial purchasing options for its NeuroStar transcranial magnetic s
- Zacks · Aug 11, 9:00 AM EDTNeuronetics (STIM) Reports Q2 Loss, Beats Revenue EstimatesNeuronetics (STIM) delivered earnings and revenue surprises of +54.55% and +3.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 11, 8:46 AM EDTNeuronetics' Q2 Revenue Rises 9%; Adjusted EBITDA Turns Positive, Narrows 2026 Outlook(RTTNews) – Neuronetics, Inc. (STIM), has announced its financial and operating results for the second quarter ended June 30, 2026.
- Zacks · Aug 6, 7:10 PM EDTShoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue EstimatesShoulder Innovations, Inc. (SI) delivered earnings and revenue surprises of 0.00% and +1.93%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Jul 21, 2:07 AM EDTNeuronetics Appoints Nir Naor CFO; Promotes Cory Anderson To Executive VP(RTTNews) – Neuronetics, Inc. (STIM), which provides treatment options for neurohealth disorders, announced that Nir Naor has been appointed Chief Financial Officer or CFO effective July 23, 2026.
- RTTNews · Jul 20, 11:01 PM EDTTop Biotech Gainers: ZYBT Skyrockets, ADVB Drops Planned Offering, STIM Gets New CFO, RDGT On Watch(RTTNews) – Today's top biotech gainers include Zhengye Biotechnology, a veterinary vaccine manufacturer, which surged, easing Nasdaq delisting concerns; Advanced Biomed, which gained after withdrawing its planned U.S. securities offering and reducing potential dilution concerns;
- The Motley Fool · May 5, 4:20 PM EDTNeuronetics (STIM) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 5, 9:15 AM EDTNeuronetics (STIM) Reports Q1 Loss, Tops Revenue EstimatesNeuronetics (STIM) delivered earnings and revenue surprises of +5.88% and +0.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Neuronetics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.